Publication | Open Access
LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer
18
Citations
0
References
2021
Year
Anti-tigit Antibody TiragolumabEsophageal CancerMedicineImmunologyMetastatic Esophageal CancerPathologyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!